Recent breakthroughs in in-vitro gametogenesis (IVG) have made the possibility of gene-edited human embryos closer to reality. Gene-editing technology, like CRISPR-Cas9, allows precise changes to DNA and is a prominent focus of scientific and public interest. Researchers have made significant advancements in IVG, using induced pluripotent stem cells (iPSCs) to create early-stage germline cells, marking a step toward lab-grown human reproductive cells.